ArticleFrontiers in pediatrics2026
Temporal trends in clinical and inflammatory features of Kawasaki disease across the COVID-19 pandemic: a single-center experience from Turkey.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The COVID-19 pandemic has been associated with changes in the epidemiology and clinical presentation of pediatric inflammatory diseases, including Kawasaki disease (KD). However, data comparing Kawasaki disease characteristics across pre-pandemic, pandemic, and post-pandemic periods remain limited. Methods: This retrospective single-center study included children diagnosed with KD between January 2015 and February 2024. Patients were classified as pre-pandemic (2015-2019), pandemic (2020-2021), or post-pandemic (2022-2024). Demographic characteristics, clinical features, laboratory findings, treatment response, and echocardiographic outcomes were compared among periods. Results: Eighty-seven patients were analyzed (pre-pandemic Conclusion: The COVID-19 pandemic was associated with changes in the inflammatory and clinical expression of Kawasaki disease without clear differences in cardiac outcomes, suggesting a greater effect on disease phenotype than on overall disease course; however, these findings should be interpreted in the context of the retrospective design and limited sample size.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.